Symbols / BCLI $0.85 +2.41% Brainstorm Cell Therapeutics Inc.
BCLI Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteBrainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is involved in the development of NurOwn, which has completed Phase IIIb clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of Alzheimer's disease, as well as for treatment of other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.
Ratings
Current target
$0.85
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-07-11 | up | Maxim Group | Hold → Buy | $2 |
| 2023-09-28 | down | Maxim Group | Buy → Hold | — |
| 2023-03-31 | main | Maxim Group | — → Buy | $10 |
| 2021-02-05 | up | Maxim Group | Hold → Buy | — |
| 2018-05-15 | init | HC Wainwright & Co. | — → Buy | $11 |
| 2017-08-17 | main | Maxim Group | — → Buy | $9 |
- BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update - PR Newswire ue, 31 Mar 2026 07
- Brainstorm Cell Therapeutics Inc (BCLI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey Wed, 17 Jun 2026 21
- Ex-FDA official joins ALS trial push after first-ever SPA for ALS - Stock Titan hu, 28 May 2026 07
- Brainstorm Cell Therapeutics Inc (BCLI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey Wed, 17 Jun 2026 21
- Brainstorm Cell (BCLI) director receives 120,000-share RSU award - Stock Titan Fri, 29 May 2026 07
- BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire Fri, 15 May 2026 07
- BCLI Stock Price and Chart — OTC:BCLI - TradingView Sat, 19 Jul 2025 18
- Brainstorm Cell (BCLI) director discloses 150,000-share stock option grant - Stock Titan Wed, 03 Jun 2026 21
- Press Release: BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update - Moomoo Fri, 15 May 2026 07
- Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February - PR Newswire hu, 26 Feb 2026 08
- Brainstorm Cell Therapeutics Stock Price Forecast. Should You Buy BCLI? - StockInvest.us ue, 01 Dec 2020 12
- Officer at Brainstorm Cell (NASDAQ: BCLI) awarded 100,000 RSUs - Stock Titan Fri, 29 May 2026 07
- BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market - PR Newswire ue, 19 May 2026 07
- BrainStorm (BCLI) CEO granted 1.8M restricted stock units as equity pay - Stock Titan Fri, 29 May 2026 07
- [EFFECT] BRAINSTORM CELL THERAPEUTICS INC. SEC Filing - Stock Titan Wed, 03 Jun 2026 10
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
9.95
-14.88%
|
11.69
-45.46%
|
21.44
-13.63%
|
24.82
|
| Research And Development |
|
4.17
-10.23%
|
4.65
-56.72%
|
10.75
-23.00%
|
13.96
|
| Selling General And Administration |
|
5.78
-17.95%
|
7.04
-34.14%
|
10.69
-1.59%
|
10.87
|
| General And Administrative Expense |
|
5.78
-17.95%
|
7.04
-34.14%
|
10.69
-1.59%
|
10.87
|
| Other Gand A |
|
5.78
-17.95%
|
7.04
-34.14%
|
10.69
-1.59%
|
10.87
|
| Total Expenses |
|
9.95
-14.88%
|
11.69
-45.46%
|
21.44
-13.63%
|
24.82
|
| Operating Income |
|
-9.95
+14.88%
|
-11.69
+45.46%
|
-21.44
+13.63%
|
-24.82
|
| Total Operating Income As Reported |
|
-9.95
+14.88%
|
-11.69
+45.46%
|
-21.44
+13.63%
|
-24.82
|
| EBITDA |
|
-9.75
+14.83%
|
-11.45
+45.91%
|
-21.17
+13.71%
|
-24.54
|
| Normalized EBITDA |
|
-9.93
+14.37%
|
-11.60
+55.16%
|
-25.87
-5.42%
|
-24.54
|
| Reconciled Depreciation |
|
0.20
-17.08%
|
0.24
-9.43%
|
0.27
-7.02%
|
0.28
|
| EBIT |
|
-9.95
+14.88%
|
-11.69
+45.46%
|
-21.44
+13.63%
|
-24.82
|
| Total Unusual Items |
|
0.18
+21.77%
|
0.15
-96.87%
|
4.69
|
—
|
| Total Unusual Items Excluding Goodwill |
|
0.18
+21.77%
|
0.15
-96.87%
|
4.69
|
—
|
| Net Income |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Pretax Income |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Net Non Operating Interest Income Expense |
|
-0.53
-592.21%
|
-0.08
+82.77%
|
-0.45
-182.02%
|
0.55
|
| Net Interest Income |
|
-0.53
-592.21%
|
-0.08
+82.77%
|
-0.45
-182.02%
|
0.55
|
| Interest Income Non Operating |
|
—
|
—
|
—
|
0.55
|
| Interest Income |
|
—
|
—
|
—
|
0.55
|
| Other Income Expense |
|
0.18
+21.77%
|
0.15
-96.87%
|
4.69
|
—
|
| Gain On Sale Of Security |
|
0.18
+21.77%
|
0.15
-96.87%
|
4.69
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Net Income From Continuing Operation Net Minority Interest |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Net Income From Continuing And Discontinued Operation |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Net Income Continuous Operations |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Normalized Income |
|
-10.49
+10.91%
|
-11.77
+46.22%
|
-21.89
+9.85%
|
-24.28
|
| Net Income Common Stockholders |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Diluted EPS |
|
-1.11
+51.95%
|
-2.31
+61.50%
|
-6.00
+39.39%
|
-9.90
|
| Basic EPS |
|
-1.11
+51.95%
|
-2.31
+61.50%
|
-6.00
+39.39%
|
-9.90
|
| Basic Average Shares |
|
9.27
+84.57%
|
5.02
+74.87%
|
2.87
+17.99%
|
2.43
|
| Diluted Average Shares |
|
9.27
+84.57%
|
5.02
+74.87%
|
2.87
+17.99%
|
2.43
|
| Diluted NI Availto Com Stockholders |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Total Other Finance Cost |
|
0.53
+592.21%
|
0.08
-82.77%
|
0.45
+182.02%
|
-0.55
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
1.02
-44.21%
|
1.83
-56.46%
|
4.21
-50.21%
|
8.45
|
| Current Assets |
|
0.31
-20.26%
|
0.39
-79.73%
|
1.90
-38.86%
|
3.11
|
| Cash Cash Equivalents And Short Term Investments |
|
0.03
-84.49%
|
0.19
-85.62%
|
1.30
-56.42%
|
2.98
|
| Cash And Cash Equivalents |
|
0.03
-84.49%
|
0.19
-85.62%
|
1.30
+68.39%
|
0.77
|
| Other Short Term Investments |
|
—
|
—
|
0.00
-100.00%
|
2.21
|
| Receivables |
|
0.09
+36.51%
|
0.06
+23.53%
|
0.05
-43.96%
|
0.09
|
| Other Receivables |
|
0.09
+36.51%
|
0.06
+23.53%
|
0.05
-43.96%
|
0.09
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
0.19
+42.22%
|
0.14
-75.36%
|
0.55
+1612.50%
|
0.03
|
| Total Non Current Assets |
|
0.71
-50.59%
|
1.45
-37.33%
|
2.31
-56.80%
|
5.34
|
| Net PPE |
|
0.44
-64.30%
|
1.24
-40.96%
|
2.10
-60.50%
|
5.32
|
| Accumulated Depreciation |
|
-3.20
-6.63%
|
-3.00
-8.69%
|
-2.76
-10.61%
|
-2.50
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.32
+0.00%
|
0.32
+0.00%
|
0.32
+0.93%
|
0.32
|
| Other Properties |
|
2.48
-19.43%
|
3.08
-16.77%
|
3.70
-44.40%
|
6.66
|
| Leases |
|
0.84
+0.00%
|
0.84
+0.00%
|
0.84
+0.00%
|
0.84
|
| Non Current Prepaid Assets |
|
—
|
—
|
0.02
-4.35%
|
0.02
|
| Other Non Current Assets |
|
0.27
+32.04%
|
0.21
-0.48%
|
0.21
+800.00%
|
0.02
|
| Total Liabilities Net Minority Interest |
|
11.01
+14.70%
|
9.60
+5.85%
|
9.07
-20.93%
|
11.47
|
| Current Liabilities |
|
11.01
+22.60%
|
8.98
+15.10%
|
7.80
-11.36%
|
8.80
|
| Payables And Accrued Expenses |
|
8.43
+20.45%
|
7.00
+13.00%
|
6.19
-1.81%
|
6.31
|
| Payables |
|
8.03
+25.92%
|
6.38
+28.78%
|
4.95
-20.40%
|
6.22
|
| Accounts Payable |
|
7.07
+16.23%
|
6.08
+22.73%
|
4.95
-20.40%
|
6.22
|
| Current Accrued Expenses |
|
0.40
-36.03%
|
0.62
-50.08%
|
1.24
+1376.19%
|
0.08
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
2.37
+65.66%
|
1.43
+42.57%
|
1.00
-5.82%
|
1.06
|
| Current Debt And Capital Lease Obligation |
|
0.21
-62.11%
|
0.55
-8.96%
|
0.60
-57.74%
|
1.43
|
| Current Capital Lease Obligation |
|
0.21
-62.11%
|
0.55
-8.96%
|
0.60
-57.74%
|
1.43
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.62
-51.18%
|
1.27
-52.51%
|
2.67
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.17
-74.55%
|
0.67
-74.79%
|
2.67
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.17
-74.55%
|
0.67
-74.79%
|
2.67
|
| Stockholders Equity |
|
-9.98
-28.61%
|
-7.76
-59.82%
|
-4.86
-61.13%
|
-3.02
|
| Common Stock Equity |
|
-9.98
-28.61%
|
-7.76
-59.82%
|
-4.86
-61.13%
|
-3.02
|
| Capital Stock |
|
0.02
+14.29%
|
0.01
+7.69%
|
0.01
+8.33%
|
0.01
|
| Common Stock |
|
0.02
+14.29%
|
0.01
+7.69%
|
0.01
+8.33%
|
0.01
|
| Share Issued |
|
11.04
+79.65%
|
6.14
+52.28%
|
4.03
+64.80%
|
2.45
|
| Ordinary Shares Number |
|
11.03
+79.67%
|
6.14
+52.30%
|
4.03
+64.85%
|
2.45
|
| Treasury Shares Number |
|
0.00
+0.00%
|
0.00
+0.06%
|
0.00
+0.00%
|
0.00
|
| Additional Paid In Capital |
|
227.06
+3.69%
|
218.97
+4.15%
|
210.26
+7.87%
|
194.91
|
| Retained Earnings |
|
-236.94
-4.55%
|
-226.64
-5.41%
|
-215.01
-8.69%
|
-197.82
|
| Treasury Stock |
|
0.12
+0.00%
|
0.12
+0.00%
|
0.12
+0.00%
|
0.12
|
| Total Equity Gross Minority Interest |
|
-9.98
-28.61%
|
-7.76
-59.82%
|
-4.86
-61.13%
|
-3.02
|
| Total Capitalization |
|
-9.98
-28.61%
|
-7.76
-59.82%
|
-4.86
-61.13%
|
-3.02
|
| Working Capital |
|
-10.70
-24.52%
|
-8.59
-45.62%
|
-5.90
-3.64%
|
-5.69
|
| Invested Capital |
|
-9.98
-28.61%
|
-7.76
-59.82%
|
-4.86
-61.13%
|
-3.02
|
| Total Debt |
|
0.21
-71.11%
|
0.72
-43.53%
|
1.27
-68.85%
|
4.09
|
| Capital Lease Obligations |
|
0.21
-71.11%
|
0.72
-43.53%
|
1.27
-68.85%
|
4.09
|
| Net Tangible Assets |
|
-9.98
-28.61%
|
-7.76
-59.82%
|
-4.86
-61.13%
|
-3.02
|
| Tangible Book Value |
|
-9.98
-28.61%
|
-7.76
-59.82%
|
-4.86
-61.13%
|
-3.02
|
| Derivative Product Liabilities |
|
0.00
-100.00%
|
0.45
-24.75%
|
0.59
|
0.00
|
| Dueto Related Parties Current |
|
0.97
+222.33%
|
0.30
|
0.00
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-6.97
+23.29%
|
-9.09
+55.55%
|
-20.46
-5.89%
|
-19.32
|
| Cash Flow From Continuing Operating Activities |
|
-6.97
+23.29%
|
-9.09
+55.55%
|
-20.46
-5.89%
|
-19.32
|
| Net Income From Continuing Operations |
|
-10.31
+11.32%
|
-11.62
+32.39%
|
-17.19
+29.18%
|
-24.28
|
| Depreciation Amortization Depletion |
|
0.20
-17.08%
|
0.24
-9.43%
|
0.27
-7.02%
|
0.28
|
| Depreciation |
|
0.20
-17.08%
|
0.24
-9.43%
|
0.27
-7.02%
|
0.28
|
| Depreciation And Amortization |
|
0.20
-17.08%
|
0.24
-9.43%
|
0.27
-7.02%
|
0.28
|
| Stock Based Compensation |
|
1.52
+102.67%
|
0.75
-49.66%
|
1.49
-11.41%
|
1.68
|
| Operating Gains Losses |
|
-0.18
-21.77%
|
-0.15
+96.75%
|
-4.53
|
—
|
| Gain Loss On Investment Securities |
|
-0.18
-21.77%
|
-0.15
+96.75%
|
-4.53
|
—
|
| Change In Working Capital |
|
1.79
+6.22%
|
1.69
+440.12%
|
-0.50
-116.59%
|
2.99
|
| Change In Receivables |
|
—
|
—
|
-0.47
-144.52%
|
1.07
|
| Change In Prepaid Assets |
|
-0.08
-120.70%
|
0.40
+184.42%
|
-0.47
|
—
|
| Change In Payables And Accrued Expense |
|
1.79
+45.13%
|
1.23
+800.00%
|
-0.18
-106.99%
|
2.52
|
| Change In Accrued Expense |
|
0.09
|
0.00
|
—
|
—
|
| Change In Payable |
|
1.70
+38.23%
|
1.23
+800.00%
|
-0.18
-106.99%
|
2.52
|
| Change In Account Payable |
|
0.99
-12.34%
|
1.13
+188.66%
|
-1.27
-150.32%
|
2.52
|
| Change In Other Current Liabilities |
|
0.09
+61.11%
|
0.05
-65.16%
|
0.15
+126.09%
|
-0.59
|
| Investing Cash Flow |
|
0.00
-100.00%
|
0.01
-99.45%
|
2.19
+119.74%
|
1.00
|
| Cash Flow From Continuing Investing Activities |
|
0.00
-100.00%
|
0.01
-99.45%
|
2.19
+119.74%
|
1.00
|
| Net PPE Purchase And Sale |
|
0.00
-100.00%
|
0.01
+166.67%
|
-0.02
+37.93%
|
-0.03
|
| Purchase Of PPE |
|
—
|
—
|
-0.02
+37.93%
|
-0.03
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.01
|
—
|
—
|
| Capital Expenditure |
|
—
|
—
|
-0.02
+37.93%
|
-0.03
|
| Net Investment Purchase And Sale |
|
0.00
|
0.00
-100.00%
|
2.21
+115.29%
|
1.03
|
| Financing Cash Flow |
|
6.88
-13.64%
|
7.97
-58.02%
|
18.98
+7873.95%
|
0.24
|
| Cash Flow From Continuing Financing Activities |
|
6.88
-13.64%
|
7.97
-58.02%
|
18.98
+7873.95%
|
0.24
|
| Net Issuance Payments Of Debt |
|
0.58
|
0.00
|
—
|
—
|
| Issuance Of Debt |
|
0.58
|
0.00
|
—
|
—
|
| Short Term Debt Issuance |
|
0.58
|
0.00
|
—
|
—
|
| Net Short Term Debt Issuance |
|
0.58
|
0.00
|
—
|
—
|
| Net Common Stock Issuance |
|
4.35
-45.44%
|
7.97
-58.02%
|
18.98
+7873.95%
|
0.24
|
| Common Stock Payments |
|
—
|
—
|
—
|
—
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
1.50
|
0.00
|
—
|
0.00
|
| Net Other Financing Charges |
|
0.45
|
—
|
—
|
—
|
| Changes In Cash |
|
-0.10
+91.47%
|
-1.11
-256.24%
|
0.71
+103.94%
|
-18.08
|
| Beginning Cash Position |
|
0.37
-75.02%
|
1.49
+92.36%
|
0.77
-95.91%
|
18.86
|
| End Cash Position |
|
0.28
-25.61%
|
0.37
-75.02%
|
1.49
+92.36%
|
0.77
|
| Free Cash Flow |
|
-6.97
+23.29%
|
-9.09
+55.59%
|
-20.48
-5.82%
|
-19.35
|
| Common Stock Issuance |
|
4.35
-45.44%
|
7.97
-58.02%
|
18.98
+7873.95%
|
0.24
|
| Issuance Of Capital Stock |
|
4.35
-45.44%
|
7.97
-58.02%
|
18.98
+7873.95%
|
0.24
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-05-29 View
- 42026-05-29 View
- 42026-05-29 View
- 42026-05-29 View
- 42026-05-29 View
- 8-K2026-05-28 View
- 42026-05-20 View
- 42026-05-20 View
- 42026-05-20 View
- 42026-05-20 View
- 42026-05-20 View
- 42026-05-20 View
- 8-K2026-05-15 View
- 10-Q2026-05-15 View
- 10-K2026-03-31 View
- 8-K2026-03-31 View
- 8-K2026-02-27 View
- 8-K2026-02-13 View
- 8-K2026-01-09 View
- 10-Q2025-11-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|